In vitro clinical trials: The future of cell-based profiling

Frontiers in Pharmacology

Volumn 5 MAY, Issue , 2014, Pages

  Ross, Nathan T ^a   Wilson, Christopher J ^a  

^a NOVARTIS INSTITUTES FOR BIOMEDICAL RESEARCH   (United States)

Author keywords

Cell line profiling; Cell panels; Genetically defined models; High throughput screening; In vitro clinical trials; Ips derived cell models

Indexed keywords

ANAPLASTIC LYMPHOMA KINASE INHIBITOR; BORTEZOMIB; DOCETAXEL; HALICHONDRIN B; ISOCITRATE DEHYDROGENASE 1; ISOCITRATE DEHYDROGENASE 2; PROTEIN KINASE INHIBITOR; SELUMETINIB; TRASTUZUMAB; UNCLASSIFIED DRUG;

ARTICLE; BREAST CANCER CELL LINE; CANCER CELL LINE; CANCER GENETICS; DRUG SCREENING; GENETIC ENGINEERING; GENETIC MODEL; GENETIC VARIABILITY; GLIOBLASTOMA; HUMAN; IN VITRO STUDY; IN VIVO STUDY; LABORATORY AUTOMATION; MEDICAL INFORMATICS; MOUSE MODEL; NONHUMAN; PATIENT CODING; PLURIPOTENT STEM CELL; SINGLE NUCLEOTIDE POLYMORPHISM; STRUCTURE ACTIVITY RELATION; TUMOR XENOGRAFT;

EID: 84904661674     PISSN: None     EISSN: 16639812     Source Type: Journal    
DOI: 10.3389/fphar.2014.00121     Document Type: Article

References (31)

1. Barretina, J., Caponigro, G., Stransky, N., Venkatesan, K., Margolin, A. A., Kim, S., et al. (2012). The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivity. Nature 483, 603-607. doi: 10.1038/nature11003
2. Bodenmiller, B., Zunder, E. R., Finck, R., Chen, T. J., Savig, E. S., Bruggner, R. V., et al. (2012). Multiplexed mass cytometry profiling of cellular states perturbed by small-molecule regulators. Nat. Biotechnol. 30, 858-867. doi: 10.1038/nbt.2317
3. Caponigro, G., and Sellers, W. R. (2011). Advances in the preclinical testing of cancer therapeutic hypotheses. Nat. Rev. Drug Discov. 10, 179-187. doi: 10.1038/nrd3385
4. Chen, Z., Cheng, K., Walton, Z., Wang, Y., Ebi, H., Shimamura, T., et al. (2012). A murine lung cancer co-clinical trial identifies genetic modifiers of therapeutic response. Nature 483, 613-617. doi: 10.1038/nature10937
5. Di Giorgio, F. P., Boulting, G. L., Bobrowicz, S., and Eggan, K. C. (2008). Human embryonic stem cell-derived motor neurons are sensitive to the toxic effect of glial cells carrying an ALS-causing mutation. Cell Stem Cell 3, 637-648. doi: 10.1016/j.stem.2008.09.017
6. Dimos, J. T., Rodolfa, K. T., Niakan, K. K., Weisenthal, L. M., Mitsumoto, H., Chung, W., et al. (2008). Induced pluripotent stem cells generated from patients with ALS can be differentiated into motor neurons. Science 321, 1218-1221. doi: 10.1126/science.1158799
7. Edwards, S. L., Beesley, J., French, J. D., and Dunning, A. M. (2013). Beyond GWASs: illuminating the dark road from association to function. Am. J. Hum. Genet. 93, 779-797. doi: 10.1016/j.ajhg.2013.10.012
8. Fallahi-Sichani, M., Honarnejad, S., Heiser, L. M., Gray, J. W., and Sorger, P. K. (2013). Metrics other than potency reveal systematic variation in responses to cancer drugs. Nat. Chem. Biol. 9, 708-714. doi: 10.1038/nchembio.1337
9. Garnett, M. J., Edelman, E. J., Heidorn, S. J., Greenman, C. D., Dastur, A., Lau, K. W., et al. (2012). Systematic identification of genomic markers of drug sensitivity in cancer cells. Nature 483, 570-575. doi: 10.1038/nature11005
10. Garraway, L. A., Widlund, H. R., Rubin, M. A., Getz, G., Berger, A. J., Ramaswamy, S., et al. (2005). Integrative genomic analyses identify MITF as a lineage survival oncogene amplified in malignant melanoma. Nature 436, 117-122. doi: 10.1038/nature03664
11. Hempel, C. M., Sivula, M., Levenson, J. M., Rose, D. M., Li, B., Sirianni, A. C., et al. (2011). A system for performing high throughput assays of synaptic function. PLoS ONE 6:e25999. doi: 10.1371/journal.pone.0025999
12. Jaffe, J. D., Wang, Y., Chan, H. M., Zhang, J., Huether, R., Kryukov, G. V., et al. (2013). Global chromatin profiling reveals NSD2 mutations in pediatric acute lymphoblastic leukemia. Nat. Genet. 45, 1386-1391. doi: 10.1038/ng.2777
13. Krey, J. F., Paşca, S. P., Shcheglovitov, A., Yazawa, M., Schwemberger, R., Rasmusson, R., et al. (2012). Timothy syndrome is associated with activity-dependent dendritic retraction in rodent and human neurons. Nat. Neurosci. 16, 201-209. doi: 10.1038/nn.3307
14. Lancaster, M. A., Renner, M., Martin, C., Wenzel, D., Bicknell, L. S., Hurles, M. E., et al. (2013). Cerebral organoids model human brain development and microcephaly. Nature 501, 373-379. doi: 10.1038/nature12517
15. Malaney, P., Nicosia, S. V., and Davé, V. (2014). One mouse, one patient paradigm: new avatars of personalized cancer therapy. Cancer Lett. 344, 1-12. doi: 10.1016/j.canlet.2013.10.010
16. McDermott, U., Iafrate, A. J., Gray, N. S., Shioda, T., Classon, M., Maheswaran, S., et al. (2008). Genomic alterations of anaplastic lymphoma kinase may sensitize tumors to anaplastic lymphoma kinase inhibitors. Cancer Res. 68, 3389-3395. doi: 10.1158/0008-5472.CAN-07-6186
17. McDermott, U., Sharma, S. V., Dowell, L., Greninger, P., Montagut, C., Lamb, J., et al. (2007). Identification of genotype-correlated sensitivity to selective kinase inhibitors by using high-throughput tumor cell line profiling. Proc. Natl. Acad. Sci. U.S.A. 104, 19936-19941. doi: 10.1073/pnas.0707498104
18. McKernan, R., and Watt, F. M. (2013). What is the point of large-scale collections of human induced pluripotent stem cells? Nat. Biotechnol. 31, 875-877. doi: 10.1038/nbt.2710
19. Nardella, C., Lunardi, A., Patnaik, A., Cantley, L. C., and Pandolfi, P. P. (2011). The APL paradigm and the "co-clinical trial" project. Cancer Discov. 1, 108-116. doi: 10.1158/2159-8290.CD-11-0061
20. Neve, R. M., Chin, K., Fridlyand, J., Yeh, J., Baehner, F. L., Fevr, T., et al. (2006). A collection of breast cancer cell lines for the study of functionally distinct cancer subtypes. Cancer Cell 10, 515-527. doi: 10.1016/j.ccr.2006.10.008
21. Paşca, S. P., Portmann, T., Voineagu, I., Yazawa, M., Shcheglovitov, A., Paşca, A. M., et al. (2011). Using iPSC-derived neurons to uncover cellular phenotypes associated with Timothy syndrome. Nat. Med. 17, 1657-1662. doi: 10.1038/nm.2576
22. Plenge, R. M., Scolnick, E. M., and Altshuler, D. (2013). Validating therapeutic targets through human genetics. Nat. Rev. Drug Discov. 12, 581-594. doi: 10.1038/nrd4051
23. Shalek, A. K., Satija, R., Adiconis, X., Gertner, R. S., Gaublomme, J. T., Raychowdhury, R., et al. (2013). Single-cell transcriptomics reveals bimodality in expression and splicing in immune cells. Nature 498, 236-240. doi: 10.1038/nature12172
24. Shankavaram, U. T., Varma, S., Kane, D., Sunshine, M., Chary, K. K., Reinhold, W. C., et al. (2009). CellMiner: a relational database and query tool for the NCI-60 cancer cell lines. BMC Genomics 10:277. doi: 10.1186/1471-2164-10-277
25. Sharma, S. V., Haber, D. A., and Settleman, J. (2010). Cell line-based platforms to evaluate the therapeutic efficacy of candidate anticancer agents. Nat. Rev. Cancer 10, 241-253. doi: 10.1038/nrc2820
26. Shcheglovitov, A., Shcheglovitova, O., Yazawa, M., Portmann, T., Shu, R., Sebastiano, V., et al. (2013). SHANK3 and IGF1 restore synaptic deficits in neurons from 22q13 deletion syndrome patients. Nature 503, 267-271. doi: 10.1038/nature12618
27. Shoemaker, R. H. (2006). The NCI60 human tumour cell line anticancer drug screen. Nat. Rev. Cancer 6, 813-823. doi: 10.1038/nrc1951
28. Solit, D. B., Garraway, L. A., Pratilas, C. A., Sawai, A., Getz, G., Basso, A., et al. (2006). BRAF mutation predicts sensitivity to MEK inhibition. Nature 439, 358-362. doi: 10.1038/nature04304
29. Ståhlberg, A., and Bengtsson, M. (2010). Single-cell gene expression profiling using reverse transcription quantitative real-time PCR. Methods 50, 282-288. doi: 10.1016/j.ymeth.2010.01.002
30. Takahashi, K., Tanabe, K., Ohnuki, M., Narita, M., Ichisaka, T., Tomoda, K., et al. (2007). Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell 131, 861-872. doi: 10.1016/j.cell.2007.11.019
31. Yazawa, M., Hsueh, B., Jia, X., Pasca, A. M., Bernstein, J. A., Hallmayer, J., et al. (2011). Using induced pluripotent stem cells to investigate cardiac phenotypes in Timothy syndrome. Nature 471, 230-234. doi: 10.1038/nature09855